Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
C. Onursal (München, Germany), L. Knüppel (München, Germany), J. Merl-Pham (München, Germany), C. D. Lietman (Houston, Texas, United States of America), R. Hatz (München, Germany), J. Behr (München, Germany), K. Unger (München, Germany), J. Hess (München, Germany), S. Hauck (München, Germany), B. Lee (Houston, Texas, United States of America), C. Staab-Weijnitz (München, Germany). Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts. 3283

Member's Comments

No comment yet.

Related content which might interest you: Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 TGF-beta-dependent inhibitor of DNA protein (Id) expression in lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 521s Year: 2006 Differential expression of the S1P transporter, Spinster homologue 2 (Spns2), in airway epithelial cells and macrophages may drive defective macrophage function in COPD Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 Composition of the cellular matrix, nutrition, and hypoxia modulate the secretion and activation of collagenases and their inhibitors in human lung cells Source: Eur Respir J 2001; 18: Suppl. 33, 244s Year: 2001 TGFß1 induces collagen deposition and increased tissue stiffness in sarcoidosis fibroblasts grown in a novel, long term, 3D culture system. Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 VEGF induces ECM synthesis and fibroblast activity in human lung fibroblasts Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Eosinophil cationic protein stimulates TGF-β1 release by human lung fibroblasts Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 The epigenetic modulator 5-aza-2’-deoxycytidine reduces the fibrotic response of human lung fibroblasts to TGFß1 in a novel, long term, 3D cell culture system. Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Differential effects of collagen I and III and vitronectin on proliferation and apoptosis of human lung fibroblasts Source: Eur Respir J 2004; 24: Suppl. 48, 105s Year: 2004 Lung fibroblasts from COPD patients presented a reduced response to TGF-β1 for proliferation and elastin synthesis Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 Low expression of cellular retinoic acid binding protein 2 and dysregulation of elastin expression in pulmonary emphysema fibroblasts Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Effect of bradykinin (BK) on human airway fibroblast (Fb) proliferation and myofibroblast (MyoFb) differentiation Source: Eur Respir J 2004; 24: Suppl. 48, 37s Year: 2004 FKBP10 regulates fibroblast migration via synthesis of collagen VI Source: ERS Lung Science Conference 2018 Year: 2018 PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Hyperoxia reversibly inhibits the transdifferentiation of alveolar type II (ATII) cells to alveolar type I (ATI) cells Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 Role of TGF-b1 in type I collagen production in bronchial epithelial cells: effects on Smad7 inhibitory role? Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Extracellular matrix (ECM) proteins in airway and in COPD mice: regional expression difference and potential mechanism mediated by TGF-ß1. Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019